Figures and Tables

From the following article:

HIV drug development: the next 25 years

Charles Flexner

Nature Reviews Drug Discovery 6, 959-966 (December 2007)

doi:10.1038/nrd2336

Figure 1 - HIV drug development: the next 25 years

Figure 1

Replication cycle of HIV with current and possible targets for antiviral intervention.

Figure 2 - HIV drug development: the next 25 years

Figure 2

Adherence to clarithromycin (for Mycobacterium avium infection) in HIV-infected patients, and variability in pharmacokinetics of lopinavir (for HIV infection).

Table 1 - HIV drug development: the next 25 years

Table 1

Licensed antiretroviral drugs, United States, 2007

Table 2 - HIV drug development: the next 25 years

Table 2

Promising investigational antiretroviral drugs, 2007*